GYN Carcinosarcoma (also known as MMMT) is a rare uterine/ovarian cancer. The GCS Project started a fund dedicated to the research of this cancer, and ever since its inception in 2016, we’ve come a long way in short period of time.
Because of the rarity of this cancer, the research on this tumor has been limited. The cancer genome atlas (TCGA) only analyzed high-grade serous ovarian cancers. Other than the GCS Project, there is currently no research solely dedicated to finding a cure for GYN Carcinosarcoma (also known as GCS or MMMT). If you make a donation to the American Cancer Society, Ovarian Cancer Research Fund, Ovarian Cancer National Alliance or other national research funds, NONE OF YOUR DONATION WILL GO TOWARDS FINDING A CURE FOR GYN CARCINOSARCOMA! If you want to make a difference towards scientific research specifically for GCS, the GCS fund will be the one to support.
For a more complete overview of the status of the research, please browse the GCS Research section to read more about why there is hope, all about the science, our research partners & specialists, the research progress, and more.
Thanks to the generosity of countless supporters for the past ten years in honor of founder Diane Redington, The GCS Project is helping change what is possible for women battling… Read More »
Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »